Abstract
Loratadine, a histamine H1 receptor antagonist, is used to treat urticaria and allergic rhinitis. Children who have trouble swallowing tablets make it difficult to administer loratadine orally. F1-F9 batches of Loratadine Tablets (ODTs) 10 mg dose were developed and tested in the present research. In this research, super disintegrants such as croscarmellose sodium, sodium starch glycolate, and crosspovidone were used to manufacture fast-dissolving tablets utilising the direct compression method. In phosphate buffer pH 6.8, the impact of various super disintegrants on tablet dissolving behaviour was examined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Research Journal of Pharmaceutical Dosage Forms and Technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
